Sustained and tumor-selective drug release from collagen nanocarriers for improved anticancer activity

Key Points

• Enhanced anticancer activity is achieved through tumor-selective drug release from collagen nanocarriers, indicating a potential breakthrough in cancer treatment.
• The study demonstrates that sustained drug release significantly improves efficacy against tumors in experimental models, emphasizing the role of targeted delivery.
• Assessment using collagen-based nanocarriers provides a novel method for efficient drug delivery, which may address current limitations in traditional therapies.
• This approach highlights the need for further research on the scalability and clinical applicability of such nanocarriers for enhanced cancer therapies.